لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Ferreira AC; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil., Reis PA; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., de Freitas CS; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil., Sacramento CQ; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil., Villas Bôas Hoelz L; Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, Brazil., Bastos MM; Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, Brazil., Mattos M; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil., Rocha N; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil., Gomes de Azevedo Quintanilha I; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., da Silva Gouveia Pedrosa C; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil., Rocha Quintino Souza L; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil., Correia Loiola E; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil., Trindade P; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil., Rangel Vieira Y; Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil., Barbosa-Lima G; Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, Brazil., de Castro Faria Neto HC; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Boechat N; Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, Brazil., Rehen SK; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.; Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Brüning K; BMK Consortium, Rio de Janeiro, Brazil., Bozza FA; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.; Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, Brazil., Bozza PT; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil., Souza TML; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil tmoreno@cdts.fiocruz.br.; Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, Brazil.; National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2019 Jan 29; Vol. 63 (2). Date of Electronic Publication: 2019 Jan 29 (Print Publication: 2019).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents/*therapeutic use , Chikungunya Fever/*drug therapy , Chikungunya virus/*drug effects , Chikungunya virus/*pathogenicity , Sofosbuvir/*therapeutic use , Virus Replication/*drug effects, Animals ; Animals, Newborn ; Arthralgia/drug therapy ; Arthralgia/virology ; Chikungunya Fever/virology ; Humans ; Male ; Mice